Orthopediatrics (KIDS) Cash from Discontinued Operations (2019)
Orthopediatrics' (KIDS) quarterly Cash from Discontinued Operations came in at 734000.0 in Q4 2019, down 435.16% on a QoQ basis from 219000.0 in Q3 2019.
Orthopediatrics (KIDS) Cash from Discontinued Operations (2019) Analysis & Trends
Orthopediatrics (KIDS) has 1 years of Cash from Discontinued Operations data on file, last reported at 734000.0 in Q4 2019.
- On a quarterly basis, Cash from Discontinued Operations changed N/A year-over-year to 734000.0 in Q4 2019; TTM through Dec 2020 was 515000.0, a 0.0% change from a year earlier, with the FY2019 full-year figure at 144000.0, changed N/A from the prior year.
- Cash from Discontinued Operations for Q4 2019 stood at 734000.0, down from 219000.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for KIDS reached as high as 219000.0 in Q3 2019 and fell as low as 734000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Orthopediatrics | 468.25 Mn | 454.01 Mn | 43.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -734,000.00 |
| Dec 31, 2019 | -734,000.00 |
| Sep 30, 2019 | 219,000.00 |
| Sep 30, 2019 | 219,000.00 |